The report provides an overview of the vaccines market. It aims at estimating the Vaccines Market size and future growth potential of this market across different segments such as technology, type, disease indication, route of administration, end user, and region.
The major players in the Vaccine Market are Pfizer, CSL Limited, Merck & Co, MedImmune.
“ReportsnReports include new market research report" Vaccine Market - Attractiveness, Competitive Landscape and Forecasts" to its huge collection of research reports.
Get Yours “Vaccine Market” sample copy @ www.reportsnreports.com/contacts/r…aspx?name=267258
“Conjugate vaccines are expected to dominate the market during the forecast period.”
By technology, the vaccines market is segmented into conjugate vaccines, inactivated and subunit vaccines, live attenuated vaccines, recombinant vaccines, and toxoid vaccines. The conjugate segment is expected to hold the largest share of the market in 2017 and is also projected to register the highest CAGR during the forecast period.
Rising prevalence of diseases and increasing government investments are the key factors driving the growth of this segment.
“Monovalent vaccines segment expected to hold the largest share of the market in 2017.”
Based on type, the vaccines market is segmented into monovalent vaccines and multivalent vaccines. The monovalent segment is expected to dominate this market with the largest share due to increasing investments by companies to develop new vaccines.
“Pneumococcal disease segment is expected to witness high growth during the forecast period”
Based on the disease indication, the vaccines market is segmented into pneumococcal disease, influenza, DTP, hepatitis, human papilloma virus (HPV), rotavirus, meningococcal disease, MMR (measles, mumps, and rubella), varicella, polio, dengue, and other disease indications. The pneumococcal segment is expected to account for the largest share and is projected to register the highest rate during the forecast period.
The growth in this segment can primarily be attributed to increasing government investments in pneumococcal vaccination programs and high incidence of pneumococcal disease.
Browse complete Vaccine Market by type 2017-2022 by new Service spreads across 204 pages profiling 15 companies and supported with 95 tables and 52 figures available at www.reportsnreports.com/reports/26…sts-to-2022.html
North America is expected to account for the largest share of the market followed by Europe. However, Asia is expected to register the highest CAGR during the forecast period.
The high growth in this segment is attributed to the increasing investments by companies in India and China, rising disposable income, growing number of awareness programs and symposia, and growing venture capital investments.
Correct Target Audience for this Vaccine Market Report are:
- Manufacturers and suppliers of vaccines
- Research and development companies
- Medical research laboratories
- Academic medical centers and universities
- Research and consulting firms
- Venture capital firms
Direct access to get complete copy of this Vaccine Market by Technology (Live, Conjugate, Toxoid, Recombinant), Disease (Influenza, DTaP, HPV, Hepatitis, Rotavirus, TT, Polio, MMR, Varicella, Dengue, TB, Rabies), Route (IM, SC, ID, Oral), End User (Pediatric, Adult) & Type - Forecast to 2022 at www.reportsnreports.com/purchase.aspx?name=267258
Fundamental from Table of Content
List of companies profiled in the report
- GlaxoSmithKline plc
- Pfizer, Inc.
- Merck & Co., Inc.
- Sanofi Pasteur SA
- CSL Limited
- Emergent BioSolutions, Inc.
- Johnson & Johnson
- MedImmune, LLC
- Astellas Pharma Inc.
- Serum Institute of India
- Bavarian Nordic
- Mitsubishi Tanabe Pharma Corporation
- Daiichi Sankyo Company, Limited
- Protein Science Corporation
- Panacea Biotec